Merck KGaA, Darmstadt, Germany
Merck KGaA, Darmstadt, Germany

Corporate history

historical photos
We are the oldest pharmaceutical and chemical company in the world. Our roots date back to the year 1668.
In order to share and document the company's history, we offer access to external visitors and researchers to the following resources at the site premises: 
 

Archive and historical library

Sources include about 2,000 meters of hand-written and printed archive material, such as letters, contracts, patents, laboratory journals, manufacturing specifications and advertisements. The oldest documents are about 400 years old. There are over 150,000 photos and films illustrating the last 150 years of corporate history.
The reference library contains more than 8,000 books and an extensive collection of journals. There is an extremely wide variety of topics, ranging from recipe and herb books of the 15th century to expert literature on corporate strategy of the 21st century.

Museum and event rooms

The museum, which features a well-stocked exhibition, the history of the company is presented as a precondition for today's success. It makes day-to-day activities in a company understandable – starting with the work in the pharmacy and industrial research, production and administration all the way to company sports, the cafeteria or the daycare center.
In addition, rooms are available for lectures small symposia and educational  museum events.
Timeline
1668Friedrich Jacob Merck acquires the Angel Pharmacy ("Engel-Apotheke")
1741Johann Heinrich Merck, Goethe's friend, is born
1827Emanuel Merck: from a pharmacy trade to a research-based industrial company
1888Comparative chemical analysis with "guaranteed pure reagents"
1900The company is represented on all continents
1904First list of finished medicinal products; Substances with liquid crystalline properties available
1917U.S. subsidiary Merck & Co. expropriated - independent ever since
1920For the first time, non-family members join the executive management
1945Loss of subsidiaries abroad, in Darmstadt new start from the ruins
1971Firm re-establishement in the United States – after Asia and Latin America
1995Establishment of Merck KGaA, Darmstadt, Germany, public listing
2003Erbitux®: Entry into targeted cancer therapy
2007Serono acquisition, divestment of Generics, capital increase, admission to the DAX®
2010Millipore acquisition

More in M – The Explorer Magazine:

DISCLAIMER

Publication of Merck KGaA, Darmstadt, Germany.
There are two different, unaffiliated companies that use the name MERCK. Merck KGaA, Darmstadt, Germany, which operates this website, uses the firm name “Merck KGaA, Darmstadt, Germany,” in the United States and Canada, and also uses “EMD Serono” in healthcare, “MilliporeSigma” in life science and “EMD Performance Materials.” The other company is Merck & Co., which uses the trademark MERCK only in the United States and Canada. Merck & Co. is not affiliated with or related to Merck KGaA, Darmstadt, Germany, which owns the MERCK trademark in all other countries of the world.  To reflect such fact and to avoid any confusion, certain logos, terms and business descriptions of the publications on this website have been substituted or modified, such as by referring to “Merck KGaA, Darmstadt, Germany” instead of “Merck” standing alone. Publications on this webpage, therefore, slightly deviate from the otherwise identical versions accessible outside the United States and Canada.
 

CONTACT:

Corporate History
Frankfurter Straße 250
64293 Darmstadt
Germany
Tel.: +49 (0)6151 72-2029
 
 
  
Read more on M - The Explorer Magazine

The right medicine

The right medicine in the right dosage - patients who need to take several different kinds of tablets can easily lose track. Our pigments should help to prevent dangerous mix-ups in the future.

Read more on M - The Explorer Magazine
Read more on M - The Explorer Magazine

Work-life balance: A future-oriented issue

A happy family life and a successful career — what’s the best way to have both? Many women in industrialized nations as well as companies and societies are asking themselves this question today.

Read more on M - The Explorer Magazine